Accepted at: May, 18, 2025
4:31 a.m.
Author:
hclu8888
Co-authors:
Stapedius
Related Deck:
1675118865074
Accepted
Rationale for new note
New Smoking cessation note
Text
What are the three (3) first line pharmacological therapies used in smoking cessation?
1. {{c1::Combination nicotine replacement therapy (NRT)}}
2. {{c1::Varenicline}}
3. {{c1::Bupropion}}
1. {{c1::Combination nicotine replacement therapy (NRT)}}
2. {{c1::Varenicline}}
3. {{c1::Bupropion}}
Text
What are the three (3) first line pharmacological therapies used in smoking cessation?<br><br>1. {{c1::Combination nicotine replacement therapy (NRT)}}<br>2. {{c1::Varenicline}}<br>3. {{c1::Bupropion}}
Extra
Combination nicotine replacement therapy (NRT) (use of a slow-acting NRT [nicotine patch] with a medium-acting form [eg gum, lozenge or inhalator] and/or a fast-acting form [nicotine mist spray])
Varenicline is a high-affinity partial agonist at nicotinic acetylcholine receptors.
Bupropion is a noradrenaline and dopamine reuptake inhibitor and a nicotinic receptor antagonist, reducing the severity of both nicotine withdrawal and cravings that persist beyond the withdrawal period
Varenicline is a high-affinity partial agonist at nicotinic acetylcholine receptors.
Bupropion is a noradrenaline and dopamine reuptake inhibitor and a nicotinic receptor antagonist, reducing the severity of both nicotine withdrawal and cravings that persist beyond the withdrawal period
Extra
Combination nicotine replacement therapy (NRT) (use of a slow-acting NRT [nicotine patch] with a medium-acting form [eg gum, lozenge or inhalator] and/or a fast-acting form [nicotine mist spray])<br><br>Varenicline is a high-affinity partial agonist at nicotinic acetylcholine receptors. <br>Bupropion is a noradrenaline and dopamine reuptake inhibitor and a nicotinic receptor antagonist, reducing the severity of both nicotine withdrawal and cravings that persist beyond the withdrawal period
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
Oxford Handbook
Empty field
Oxford Handbook
First Aid
Empty field
First Aid
AMBOSS
Empty field
AMBOSS
eTG Complete
eTG Complete
Source: <a href="https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Addiction%20Medicine&topicfile=c_AMG_Overview-of-tobacco-smoking-and-nicotine-dependence_topic_1&guidelinename=auto§ionId=c_AMG_Overview-of-tobacco-smoking-and-nicotine-dependence_topic_1#c_AMG_Overview-of-tobacco-smoking-and-nicotine-dependence_topic_1">https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Addiction Medicine&topicfile=c_AMG_Overview-of-tobacco-smoking-and-nicotine-dependence_topic_1&guidelinename=auto&sectionId=c_AMG_Overview-of-tobacco-smoking-and-nicotine-dependence_topic_1#c_AMG_Overview-of-tobacco-smoking-and-nicotine-dependence_topic_1</a> Accessed 03/04/2025
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Source
Empty field
Source
One by one
Empty field
One by one
Tags
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Respiratory_Medicine
#Malleus_CM::#Subjects::Respiratory_Medicine::*General::Procedures::Smoking_Cessation
#Malleus_CM::#Pharmacology::18_Psychotropic_drugs::07_Drugs_for_nicotine_dependence::Varenicline::03_Indications
#Malleus_CM::#Resources_by_Rotation::Psychiatry
#Malleus_CM::#Pharmacology::18_Psychotropic_drugs::07_Drugs_for_nicotine_dependence::Bupropion::03_Indications
#Malleus_CM::#Pharmacology::18_Psychotropic_drugs::07_Drugs_for_nicotine_dependence::Nicotine::03_Indications